Under construction – not a live service
Sign in
Not yet taking people in BelgiumPhase 1

Early safety study of GL0071 injections in healthy, overweight and obese adults

Tests GL0071 given by injection for safety in healthy, overweight and obese adults.

Key facts

Who runs it
Sun Pharmaceutical Industries Limited
Where
Liege, BelgiumSee the site
Registry title
A first-in-human, randomized, double-blind, placebo-controlled, 3-part study assessing the safety, tolerability, pharmacodynamics and pharmacokinetics of GL0071 after single and repeated ascending subcutaneous doses in healthy normal weight, overweight and obese participants, as well as a 12-week treatment randomized, double blind, placebo-controlled exploratory Proof-of-Concept study in overweight and obese participants.
Status
Not yet recruiting
Phase
Phase 1
People taking part
124 people, planned
Started
28 Sept 2026
Expected to end
26 Feb 2027
Type of study
Interventional
Record updated
27 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are healthy and of normal weight, overweight or obese, to test the safety of a new injected medicine called GL0071. Overweight and obese people can also join a 12-week exploratory part.

Age
18 to 64 years
Sex
All sexes can join.

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Belgium

  • InokuraLiege, BelgiumNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Early safety study of GL0071 injections in healthy, overweight and obese adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2025-524233-45-00, who can take part
Record updated
27 July 2026